205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.40%
Revenue decline while MRVL shows 0.00% growth. Joel Greenblatt would examine competitive position erosion.
-4.26%
Cost reduction while MRVL shows 0.00% growth. Joel Greenblatt would examine competitive advantage.
-29.55%
Gross profit decline while MRVL shows 0.00% growth. Joel Greenblatt would examine competitive position.
-15.72%
Margin decline while MRVL shows 0.00% expansion. Joel Greenblatt would examine competitive position.
1.13%
R&D change of 1.13% while MRVL maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.70%
Operating expenses reduction while MRVL shows 0.00% growth. Joel Greenblatt would examine advantage.
-4.76%
Total costs reduction while MRVL shows 0.00% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
247.08%
D&A change of 247.08% while MRVL maintains D&A. Bruce Berkowitz would investigate efficiency.
88.10%
EBITDA change of 88.10% while MRVL is flat. Bruce Berkowitz would examine quality.
125.00%
Margin change of 125.00% while MRVL is flat. Bruce Berkowitz would examine quality.
-62.46%
Operating income decline while MRVL shows 0.00% growth. Joel Greenblatt would examine position.
-55.09%
Operating margin decline while MRVL shows 0.00% growth. Joel Greenblatt would examine position.
-64.59%
Other expenses reduction while MRVL shows 0.00% growth. Joel Greenblatt would examine advantage.
-63.09%
Pre-tax income decline while MRVL shows 0.00% growth. Joel Greenblatt would examine position.
-55.85%
Pre-tax margin decline while MRVL shows 0.00% growth. Joel Greenblatt would examine position.
-56.10%
Tax expense reduction while MRVL shows 0.00% growth. Joel Greenblatt would examine advantage.
-63.67%
Net income decline while MRVL shows 0.00% growth. Joel Greenblatt would examine position.
-56.54%
Net margin decline while MRVL shows 0.00% growth. Joel Greenblatt would examine position.
-65.79%
EPS decline while MRVL shows 0.00% growth. Joel Greenblatt would examine position.
-64.86%
Diluted EPS decline while MRVL shows 0.00% growth. Joel Greenblatt would examine position.
2.06%
Share count change of 2.06% while MRVL is stable. Bruce Berkowitz would verify approach.
-12.19%
Diluted share reduction while MRVL shows 0.00% change. Joel Greenblatt would examine strategy.